These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9679540)

  • 1. Thioredoxin redox control of cell growth and death and the effects of inhibitors.
    Powis G; Kirkpatrick DL; Angulo M; Baker A
    Chem Biol Interact; 1998 Apr; 111-112():23-34. PubMed ID: 9679540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenium and the thioredoxin redox system: effects on cell growth and death.
    Powis G; Gasdaska JR; Gasdaska PY; Berggren M; Kirkpatrick DL; Engman L; Cotgreave IA; Angulo M; Baker A
    Oncol Res; 1997; 9(6-7):303-12. PubMed ID: 9406236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox active disulfides: the thioredoxin system as a drug target.
    Kirkpatrick DL; Ehrmantraut G; Stettner S; Kunkel M; Powis G
    Oncol Res; 1997; 9(6-7):351-6. PubMed ID: 9406241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thioredoxin/thioredoxin reductase redox system and control of cell growth.
    Powis G; Oblong JE; Gasdaska PY; Berggren M; Hill SR; Kirkpatrick DL
    Oncol Res; 1994; 6(10-11):539-44. PubMed ID: 7620223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A redox-inactive thioredoxin reduces growth and enhances apoptosis in WEHI7.2 cells.
    Freemerman AJ; Powis G
    Biochem Biophys Res Commun; 2000 Jul; 274(1):136-41. PubMed ID: 10903908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the redox protein thioredoxin in cell growth and cancer.
    Powis G; Mustacich D; Coon A
    Free Radic Biol Med; 2000 Aug; 29(3-4):312-22. PubMed ID: 11035260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties and biological activities of thioredoxins.
    Powis G; Montfort WR
    Annu Rev Pharmacol Toxicol; 2001; 41():261-95. PubMed ID: 11264458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides.
    Kirkpatrick DL; Kuperus M; Dowdeswell M; Potier N; Donald LJ; Kunkel M; Berggren M; Angulo M; Powis G
    Biochem Pharmacol; 1998 Apr; 55(7):987-94. PubMed ID: 9605422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties and biological activities of thioredoxins.
    Powis G; Montfort WR
    Annu Rev Biophys Biomol Struct; 2001; 30():421-55. PubMed ID: 11441809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial thioredoxin system: effects of TrxR2 overexpression on redox balance, cell growth, and apoptosis.
    Patenaude A; Ven Murthy MR; Mirault ME
    J Biol Chem; 2004 Jun; 279(26):27302-14. PubMed ID: 15082714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy.
    Pennington JD; Jacobs KM; Sun L; Bar-Sela G; Mishra M; Gius D
    Curr Pharm Des; 2007; 13(33):3368-77. PubMed ID: 18045191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.
    Engman L; Cotgreave I; Angulo M; Taylor CW; Paine-Murrieta GD; Powis G
    Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system.
    Sun Y; Rowehl LM; Huang L; Mackenzie GG; Vrankova K; Komninou D; Rigas B
    Breast Cancer Res; 2012 Jan; 14(1):R20. PubMed ID: 22293394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel syntheses of disulfide inhibitors of the thioredoxin redox system as potential antitumor agents.
    Kirkpatrick DL; Watson S; Kunkel M; Fletcher S; Ulhaq S; Powis G
    Anticancer Drug Des; 1999 Oct; 14(5):421-32. PubMed ID: 10766297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy.
    Biaglow JE; Miller RA
    Cancer Biol Ther; 2005 Jan; 4(1):6-13. PubMed ID: 15684606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells.
    Gallegos A; Gasdaska JR; Taylor CW; Paine-Murrieta GD; Goodman D; Gasdaska PY; Berggren M; Briehl MM; Powis G
    Cancer Res; 1996 Dec; 56(24):5765-70. PubMed ID: 8971189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism.
    Gasdaska JR; Berggren M; Powis G
    Cell Growth Differ; 1995 Dec; 6(12):1643-50. PubMed ID: 9019170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New inhibitors of the thioredoxin-thioredoxin reductase system based on a naphthoquinone spiroketal natural product lead.
    Wipf P; Hopkins TD; Jung JK; Rodriguez S; Birmingham A; Southwick EC; Lazo JS; Powis G
    Bioorg Med Chem Lett; 2001 Oct; 11(19):2637-41. PubMed ID: 11551767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase.
    Ganther HE
    Carcinogenesis; 1999 Sep; 20(9):1657-66. PubMed ID: 10469608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of disulfides as anticancer agents with thioredoxin inhibition.
    Wei X; Zhong M; Wang S; Li L; Song ZL; Zhang J; Xu J; Fang J
    Bioorg Chem; 2021 May; 110():104814. PubMed ID: 33756234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.